Trial :

COVID-19 Study

Age :

18 +

Trial length :

26 Weeks

Info :

13 visits

We are evaluating the safety and tolerability of an experimental new drug that will address a gap in current knowledge by investigating a new agent in the prevention of COVID-19.

For this trial we need the help of healthy males and females that are not pregnant, not able to bear children or are on adequate contraception, and who are 18 or above.

If you meet the criteria for this study and would like more information, register below or call 1800 727 874.

This study is a 26 week study which includes 13 outpatient visits.

To be eligible you must:

  1. Be 18 years and over
  2. Agree to continue adequate contraception throughout the study period.
  3. Be willing and able to adhere to the follow-up schedule.